Back to Search Start Over

Risk factor assessment and microbiome analysis in peritoneal dialysis-related peritonitis reveal etiological characteristics.

Authors :
Zhang L
Zhang H
Su S
Jia Y
Liang C
Fang Y
Hong D
Li T
Ma F
Source :
Frontiers in immunology [Front Immunol] 2024 Nov 14; Vol. 15, pp. 1443468. Date of Electronic Publication: 2024 Nov 14 (Print Publication: 2024).
Publication Year :
2024

Abstract

Background: Peritoneal dialysis-related peritonitis (PDRP) is one of the most common complications of peritoneal dialysis (PD). Understanding the risk factors and etiological characteristics is indispensable for infection prevention and improving the outcome and life quality.<br />Methods: A total of 70 PD patients were separated into the PDRP group (n=25) and the control group (n=45). Variables, including gender, age, body mass index, primary diseases, and history of basic diseases, in the two groups were analyzed to assess the risk factors of PDRP. Metagenomic next-generation sequencing (mNGS) and microbial culture were compared in detecting pathogenic microorganisms. Gut microbiota analysis was performed in 35 PDRP patients based on mNGS data.<br />Results: Dialysis time and times of dialysate change were the risk factors of PDRP, and times of dialysate change was the independent risk factor of PDRP (p = 0.046). mNGS produced higher sensitivity (65.79%) than microbial culture (36.84%) in identifying pathogenic microorganisms. Staphylococcus aureus and Klebsiella pneumoniae (four cases) were the most frequent pathogens causing PDRP, followed by Staphylococcus capitis (three cases). β diversity of the gut microbiota was significantly different between patients with fewer times of dialysate change (≤4) and more (>5), as well as between patients with gram-positive (G+) bacterial and gram-negative (G-) bacterial infection.<br />Conclusion: The dialysis time and times of dialysate changes not only are risk factors for peritonitis in PD patients but also stimulate significant changes in the gut microbiome structure in PDRP patients. These findings may provide a novel viewpoint for the management of patients with PDRP.<br />Competing Interests: YF, DH, and TL are employees of the company Genoxor Medical Science and Technology Inc., which commercializes mNGS detection and data analysis to identify microorganisms. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2024 Zhang, Zhang, Su, Jia, Liang, Fang, Hong, Li and Ma.)

Details

Language :
English
ISSN :
1664-3224
Volume :
15
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Academic Journal
Accession number :
39611142
Full Text :
https://doi.org/10.3389/fimmu.2024.1443468